Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.340
-0.070 (-1.59%)
Apr 28, 2026, 1:01 PM EDT - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $603.24 million as of April 28, 2026. Its market cap has increased by 417.57% in one year.
Market Cap
603.24M
Enterprise Value
463.72M
1-Year Change
417.57%
Ranking
Category
Stock Price
$4.34
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $603.24M, an increase of 181.29%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 612.97M | 87.96% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 631.04M |
| Absci | 602.90M |
| Zevra Therapeutics | 595.88M |
| Adlai Nortye | 592.00M |
| ProKidney | 585.80M |
| Shattuck Labs | 585.00M |
| CorMedix | 581.94M |
| Prothena Corporation | 578.70M |